Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy

Published:2020-08-11 Issue:1 Volume:39 Page:269-271
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Ishii Hidenobu,Azuma Koichi,Kawahara Akihiko,Matsuo Norikazu,Tokito Takaaki,Hoshino Tomoaki

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10637-020-00983-6.pdf

Reference9 articles.

1. Jackman DM, Johnson BE (2005) Small-cell lung cancer. Lancet 366:1385–1396. https://doi.org/10.1016/S0140-6736(05)67569-1

2. Rocha Lima CM, Chiappori A (2003) Treatment of relapsed small-cell lung Cancer--a focus on the evolving role of Topotecan. Lung Cancer 40:229–236. https://doi.org/10.1016/s0169-5002(03)00039-4

3. Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252–264. https://doi.org/10.1038/nrc3239

4. Horn L, Mansfield AS, Szczęsna A et al (2018) First-line Atezolizumab plus chemotherapy in extensive-stage small-cell lung Cancer. N Engl J Med 379:2220–2229. https://doi.org/10.1056/NEJMoa1809064

5. Paz-Ares L, Dvorkin M, Chen Y et al (2019) Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet 394:1929–1939. https://doi.org/10.1016/S0140-6736(19)32222-6

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Nursing Method of Psychological Intervention Combined with Health Education on Lung Cancer Patients Undergoing Chemotherapy;Journal of Healthcare Engineering;2022-02-16

2. The efficacy and safety of immune checkpoint inhibitor in patients with relapsed small‐cell lung cancer: A systematic review and meta‐analysis;Journal of Clinical Pharmacy and Therapeutics;2021-11-03

3. Atezolizumab/carboplatin/etoposide;Reactions Weekly;2021-09

4. Staged versus conventional nursing for patients receiving chemotherapy for advanced non-small cell lung cancer: a before and after study;Annals of Palliative Medicine;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3